4//SEC Filing
WILSON GAYLE E 4
Accession 0001127602-19-007332
CIK 0000882095other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 8:06 PM ET
Size
8.2 KB
Accession
0001127602-19-007332
Insider Transaction Report
Form 4
WILSON GAYLE E
Director
Transactions
- Exercise/Conversion
Common Stock
2019-02-19+19,068→ 143,567 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2019-02-19−19,068→ 0 totalExercise: $22.02Exp: 2019-05-06→ Common Stock (19,068 underlying) - Sale
Common Stock
2019-02-19$67.08/sh−19,068$1,279,074→ 124,499 total
Footnotes (2)
- [F1]Sale prices reported for the transactions reported here range from $67.07 to $67.10. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F2]The options vested quarterly over the first year of service and were fully vested on May 6, 2010.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001198227
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 8:06 PM ET
- Size
- 8.2 KB